We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

16 hedge funds and large institutions have $4.94M invested in ImmuCell in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.01% less ownership

Funds ownership: 12.45% → 12.44% (-0.01%)

16% less funds holding

Funds holding: 19 → 16 (-3)

17% less capital invested

Capital invested by funds: $5.98M → $4.94M (-$1.04M)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
16
Holders Change
-3
Holders Change %
-15.79%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$95.2K
2
Wells Fargo
Wells Fargo
California
+$80.5K
3
UBS Group
UBS Group
Switzerland
+$7.78K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$146K
2
EIM
Essex Investment Management
Massachusetts
-$23.7K
3
Deutsche Bank
Deutsche Bank
Germany
-$17.6K
4
Renaissance Technologies
Renaissance Technologies
New York
-$13.2K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$12K
Name Holding Trade Value Shares
Change 		Change in
Stake
HA
1
Heartland Advisors
Wisconsin
$1.4M – – –
PCM
2
Perritt Capital Management
Illinois
$1.25M – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$645K -$13.2K -1,800 -2%
SRC
4
Shufro Rose & Co
New York
$342K – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$321K +$95.2K +13,000 +40%
Wells Fargo
6
Wells Fargo
California
$238K +$80.5K +11,000 +48%
EIM
7
Essex Investment Management
Massachusetts
$224K -$23.7K -3,236 -9%
EFS
8
Essex Financial Services
Connecticut
$166K – – –
MA
9
Minerva Advisors
Pennsylvania
$102K – – –
RC
10
RBF Capital
California
$92K – – –
Morgan Stanley
11
Morgan Stanley
New York
$89K -$2.2K -300 -2%
UBS Group
12
UBS Group
Switzerland
$35K +$7.78K +1,062 +27%
Deutsche Bank
13
Deutsche Bank
Germany
$20K -$17.6K -2,399 -45%
Bank of America
14
Bank of America
North Carolina
$15K – – –
BlackRock
15
BlackRock
New York
$5K – – –
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
– -$146K -16,600 Closed
Acadian Asset Management
17
Acadian Asset Management
Massachusetts
– -$12K -1,372 Closed

ICCC Hedge Fund Activity: Q1 2018 in Review

16 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q1 2018, worth a combined $4.94M — down 17% from $5.98M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ICCC and 0 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 3 added.

The largest buyer was Vanguard Group, adding an estimated $95.2K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $146K sold.

  • 16 institutional investors held ImmuCell (ICCC) as of Q1 2018, down from 19 in Q4 2017.
  • Funds reported $4.94M of ImmuCell stock for Q1 2018, down 17% quarter-over-quarter.
  • 0 funds opened new ImmuCell positions in Q1 2018 and 3 closed out, a net change of -3 holders.
  • The largest ImmuCell buyer in Q1 2018 was Vanguard Group, an estimated $95.2K added.
  • The largest ImmuCell seller in Q1 2018 was Susquehanna International Group, an estimated $146K sold.

Based on aggregated 13F filings for Q1 2018.